{"url":"https://lda.senate.gov/api/v1/filings/ddcbacd2-ff8d-4e77-84ce-c73881d2ffdb/","filing_uuid":"ddcbacd2-ff8d-4e77-84ce-c73881d2ffdb","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ddcbacd2-ff8d-4e77-84ce-c73881d2ffdb/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jodie Curtis","dt_posted":"2021-07-19T16:04:49.677000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K St NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.senate.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-01-29T11:30:12.415915-05:00"},"client":{"id":206449,"url":"https://lda.senate.gov/api/v1/clients/206449/","client_id":1006524,"name":"SIMON WILLIAMS PHARMA CONSULTING (SWPC) LLC","general_description":"Pharmaceutical Consulting Firm.","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pandemic preparedness; Medical device federal contracts; Opioid overdose treatment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":35565,"prefix":null,"prefix_display":null,"first_name":"JODIE","nickname":null,"middle_name":null,"last_name":"CURTIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69713,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":"A","last_name":"HANEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}